LARP1 regulates metabolism and mTORC1 activity in cancer
Chettle, J.; Dedeic, Z.; Fischer, R.; Vendrell, I.; Campo, L.; Easton, A.; Browne, M.; Morris, J.; Schwenzer, H.; Lascaux, P.; Gijsbers, R.; Pires, E.; Royston, D. J.; Ferguson, D. J. P.; Coosemans, A.; Kessler, B.; McCullagh, J.; Ahmed, A. A.; Ramadan, K.; Bushell, M.; Harris, A. L.; Goding, C. R.; Blagden, S. P.
Show abstract
The protein mammalian target of rapamycin (mTOR) is a master regulator of cell homeostasis. Although mTOR is aberrantly overactivated in 70% ovarian cancers, mTOR cascade inhibitors (such as those blocking the kinase activity of mTOR itself or upstream kinases PI3K/AKT) have demonstrated disappointing activity in ovarian cancer clinical trials. These findings indicate that, despite its pivotal role in normal cells, hyperactivated mTOR does not act as a master regulator of metabolism in this cancer context. Surprisingly, we have identified that the RNA binding protein LARP1, a known phospho-target of mTORC1 and activator of ribosomal biogenesis, is responsible for metabolic reprogramming in mTOR-dysregulated cancers. LARP1 post-transcriptionally regulates the expression of several hundred rate-limiting enzymes involved in multiple aspects of metabolism, including glycolysis and oxidative phosphorylation. Through this mechanism LARP1 sustains ATP production and mTORC1 localisation on the lysosome, thereby activating cell proliferation despite the scarcity of extracellular nutrients. Our findings show that, by sustaining global cellular metabolism in response to growth factor signalling, LARP1 has a central post-transcriptional role in controlling mTORC1 localisation and driving cancer progression, a key cancer hallmark.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma. 95%
- P-cadherin mechanoactivates tumor- mesothelium metabolic coupling to promote ovarian cancer metastasis 95%
- An Aurora kinase A-BOD1L1-PP2A B56 Axis promotes chromosome segregation fidelity 95%
Similar papers in this journal
- Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer 94%
- Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma 94%
- Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation 94%
Similar papers in this journal
- Co-regulation and functional cooperativity of FOXM1 and RHNO1 bidirectional genes in ovarian cancer 94%
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor 94%
- Limited inhibition of multiple nodes in a driver network blocks metastasis 94%
Similar papers in this journal
Similar papers in this journal
- Pro-survival roles for p21(Cip1/Waf1) in Non-Small Cell Lung Cancer 94%
- Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer 94%
- Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.